Sign up to save your podcasts
Or
Share MDT perspectives on biologic treatment selection in severe type 2 asthm
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MDT perspectives on biologic treatment selection in severe type 2 asthm
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.
The multidisciplinary team
- Allergist: Professor Ioana Agache, Romania
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/
View all episodes
By touchpodcasttouchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.
The multidisciplinary team
- Allergist: Professor Ioana Agache, Romania
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/